Preventing infusate injuries throughout a child’s hospitalisatio

Not Applicable

Recruiting

• Conditions: Extravasation injuries (caused by peripheral intravenous catheters of infants); Injuries and Accidents - Other injuries and accidents

• Registration Number: ACTRN12623000561684
• Lead Sponsor: niversity of Queensland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-05-25
• Last Update Posted: 12 December 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 532

Inclusion Criteria

1) Neonates (greater than or equal to 1250 grams + physically able to fit the IV sensor on the limb)

2) Infants younger than one year

3) Have an existing or new peripheral IVs (including long and traditional peripheral IV) inserted in the distal half of a limb (i.e. proximal to antecubital for upper limb).

4) Peripheral IV anticipated to be in situ for >24 hours,

5) Planned administration via the study peripheral IV of either:
-continuous fluids (for 4 hours or more) including blood products.
-antimicrobials, or
-intermediate to high risk infusates .

Exclusion Criteria

1) Planned administration of lipid-based infusate via study peripheral IV (e.g., propofol).

2) Other types of vascular access devices, including midline catheters, peripheral arterial catheters and central venous catheters

3) Pre-existing skin condition effecting study peripheral IV site, e,g., i) atopic dermatitis or extensive erythema toxicum, ii) infectious diseases such as Staphylococcal scalded skin syndrome; iii) burn (e.g., heat, decontamination); iv) inherited conditions such as epidermolysis bullosa, ichthyosis and aplasia cutis congenita

4) Previously enrolled in this study and randomized to one of the treatment conditions

5) Currently receiving end of life and/or redirection of care.

Study & Design

• Study Type: Interventional
• Study Design: Not specified